AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline
pharmaceutical-investing Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
pharmaceutical-investing Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
pharmaceutical-investing Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
pharmaceutical-investing Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
